Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature is a research paper published in Arthritis & Rheumatology (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: N01‐AR‐2‐2265
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: NIAMS N01‐AR‐2‐2265
UCLH Biomedical Research Centre
Grant: BRC773/III/CC/101350
Versus Arthritis
Grant: 22856
Versus Arthritis
Grant: 22908
Versus Arthritis
Grant: 20164
Intramural NIH HHS
Grant: Z99 AR999999
NIAMS NIH HHS
Grant: NIAMS N01-AR-2-2265
Versus Arthritis
Grant: 21593
FWCI
3.81
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals